NovoCure (NVCR) Revenue Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 8.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 16.70% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.08% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 15.05% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 7.41% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.29% |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn | 12.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.30% |
| Dec 31, 2025 | 8.11% |
| Sep 30, 2025 | 7.81% |
| Jun 30, 2025 | 5.62% |
| Mar 31, 2025 | 11.91% |
| Dec 31, 2024 | 20.54% |
| Sep 30, 2024 | 21.81% |
| Jun 30, 2024 | 19.28% |
| Mar 31, 2024 | 13.36% |
| Dec 31, 2023 | 4.17% |
| Sep 30, 2023 | -2.81% |
| Jun 30, 2023 | -10.52% |
| Mar 31, 2023 | -11.17% |
| Dec 31, 2022 | -3.59% |
| Sep 30, 2022 | -1.95% |
| Jun 30, 2022 | 5.50% |
| Mar 31, 2022 | 2.12% |
| Dec 31, 2021 | -7.46% |
| Sep 30, 2021 | 0.71% |
| Jun 30, 2021 | 15.18% |
| Mar 31, 2021 | 32.28% |
| Dec 31, 2020 | 45.06% |
| Sep 30, 2020 | 44.10% |
| Jun 30, 2020 | 33.69% |
| Mar 31, 2020 | 38.90% |
| Dec 31, 2019 | 42.43% |
| Sep 30, 2019 | 42.17% |
| Jun 30, 2019 | 40.96% |
| Mar 31, 2019 | 40.64% |
| Dec 31, 2018 | 29.84% |
| Sep 30, 2018 | 29.23% |
| Jun 30, 2018 | 60.29% |
| Mar 31, 2018 | 49.44% |
| Dec 31, 2017 | 77.44% |
| Sep 30, 2017 | 131.19% |
| Jun 30, 2017 | 114.16% |
| Mar 31, 2017 | 167.22% |
| Dec 31, 2016 | 144.22% |
| Sep 30, 2016 | 142.09% |
| Jun 30, 2016 | 173.87% |
| Mar 31, 2016 | 150.63% |
| Dec 31, 2015 | 225.78% |
| Sep 30, 2015 | 104.69% |